Original Research

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Fong R, Cavet ME, DeCory HH, Vittitow JL

Clinical Ophthalmology 2019, 13:1427-1438

Published Date: 1 August 2019